Daxas

DRUG2 trials

Sponsors

AstraZeneca

Conditions

Chronic Obstructive Pulmonary DiseaseSevere COPD

Unknown Phase

Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe Chronic Obstructive Pulmonary Disease (COPD) (DACOTA)

CompletedNCT01285167

AstraZenecaChronic Obstructive Pulmonary Disease

Start: 2010-08-31End: 2012-02-29Updated: 2016-10-31

Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe COPD

CompletedNCT01285180

AstraZenecaSevere COPD

Start: 2010-08-31End: 2012-08-31Updated: 2016-10-28